Johnson & Johnson (JNJ)

$ 207.49
   
  • Change Today:
    $2.70
  • 52 Week High: $214.17
  • 52 Week Low: $142.06
  • Currency: US Dollars
  • Shares Issued: 2,406.92m
  • Volume: 7,545,920
  • Market Cap: $499,412m
  • RiskGrade: 87
  • Beta: 0.10

Latest ShareCast News

Johnson & Johnson beefs up oncology pipeline with $3bn Halda acquisition

By Benjamin Chiou

Date: Monday 17 Nov 2025

(Sharecast News) - American pharma and medical giant Johnson & Johnson has announced the $3.05bn acquisition of clinical-stage biotech company Halda Therapeutics in hopes that the company can revolutionise the treatment of cancer.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Johnson and Johnson Market Data

Currency US Dollars
Share Price $ 207.49
Change Today $ 2.70
% Change 1.32 %
52 Week High $214.17
52 Week Low $142.06
Volume 7,545,920
Shares Issued 2,406.92m
Market Cap $499,412m
Beta 0.10
RiskGrade 87

What The Brokers Say

Strong Buy 6
Buy 8
Neutral 12
Sell 0
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 07-Jan-2026

Time Volume / Share Price
16:00 1,217,849 @ $207.49
15:59 644 @ $207.47
15:59 255 @ $207.48
15:59 150 @ $207.49
15:59 253 @ $207.49

Top of Page